Enbiosis is a London-based biotechnology company that develops Digital Twin & AI-powered, clinically validated nutraceutical formulations targeting the gut microbiome.
Enbiosis is headquartered in London, UK.
Unlike traditional supplements that rely on trial-and-error, Enbiosis uses Digital Twin & AI technology to design precision formulations for specific health conditions, clinically validated and food-grade.
The gut microbiome is a community of trillions of microorganisms in the digestive system that influences metabolism, immune function, brain health, hormonal balance, and more.
The gut microbiome is one of the body’s most powerful regulatory systems, linked to the vast majority of known health conditions. By targeting the gut, it becomes possible to address a broad range of health conditions across multiple body systems, from metabolic and brain health to immune function, skin, and eye health.
Yes. Diet, lifestyle, environment, and genetics all shape the gut microbiome differently across regions and populations. This means an ingredient that works well in one population may produce different results in another.
Enbiosis uses computational modelling to account for this variability, designing formulations that work across diverse microbiome profiles rather than a single population average.
